Cargando…

Therapeutic effects and prognostic factors of (125)I brachytherapy for pelvic recurrence after early cervical cancer surgery

To investigate the efficacy of (125)I seed implantation in the treatment regimen of pelvic recurrence after early cervical cancer surgery and to analyse prognostic factors. To evaluate efficacy and analyse prognostic factors of (125)I seed implantation for pelvic recurrence after early cervical canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Rui, Zhu, Jinhu, Yang, Shu, Chen, Xiaoqin, Gu, Cairu, Liang, Tong, Li, Ling, Liu, Dan, Cao, Yanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166881/ https://www.ncbi.nlm.nih.gov/pubmed/34059692 http://dx.doi.org/10.1038/s41598-021-90007-x

Ejemplares similares

CT-guided (125)I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy
por: Tong, Lina, et al.
Publicado: (2017)

CT-guided (125)I brachytherapy for recurrent ovarian cancer
por: Liu, Ping, et al.
Publicado: (2017)

Evaluation of therapeutic effects of (125)I particles brachytherapy for recurrent bladder cancer
por: Zhou, Yu-Ming, et al.
Publicado: (2018)

Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model
por: Brun, Thomas, et al.
Publicado: (2018)

Palliative treatment of pelvic bone tumors using radioiodine ((125)I) brachytherapy
por: Wang, Chongren, et al.
Publicado: (2016)

Feasibility of (125)I brachytherapy combined with arterial infusion chemotherapy in patients with advanced pancreatic cancer
por: Huang, Shujing, et al.
Publicado: (2023)

Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer
por: Jiang, Qin, et al.
Publicado: (2021)

CT-guided (125)I brachytherapy for locally recurrent nasopharyngeal carcinoma
por: Yan, Huzheng, et al.
Publicado: (2017)

(125)I Seed Brachytherapy for Refractory Loco-Regional Recurrence of Non-Anaplastic Thyroid Cancer
por: Yu, Huimin, et al.
Publicado: (2022)

Combination of (125)I brachytherapy and chemotherapy for unresectable recurrent breast cancer: A retrospective control study
por: Tan, Qixing, et al.
Publicado: (2016)

A novel three-dimensional template combined with MR-guided (125)I brachytherapy for recurrent glioblastoma
por: He, Xiangmeng, et al.
Publicado: (2020)

Treatment planning considerations for (125)I eye plaque brachytherapy
por: Miguel, David, et al.
Publicado: (2019)

Annulus-shaped I-125 plaque brachytherapy for conjunctival melanoma
por: Berkowitz, Sean T., et al.
Publicado: (2022)

A commentary on (125)I seed brachytherapy for refractory loco-regional recurrence of non-anaplastic thyroid cancer
por: Wang, Yamei, et al.
Publicado: (2022)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Comparative cost-effectiveness of focal and total salvage (125)I brachytherapy for recurrent prostate cancer after primary radiotherapy
por: Peters, Max, et al.
Publicado: (2016)

Computed tomography-guided implantation of (125)I seeds brachytherapy for recurrent multiple pulmonary oligometastases: initial experience and results
por: Li, Jie, et al.
Publicado: (2017)

Analysis of local recurrence causes in uveal melanoma patients treated with (125)I brachytherapy – a single institution study
por: Kowal, Joanna, et al.
Publicado: (2019)

Quality of life in patients who underwent (125)I brachytherapy, (125)I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer
por: Nakai, Yasushi, et al.
Publicado: (2019)

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Bioevaluation of (125)I Ocu-Prosta seeds for application in prostate cancer brachytherapy
por: Mukherjee, Archana, et al.
Publicado: (2014)

Re-implantation after insufficient primary 125-i permanent prostate brachytherapy
por: Putora, Paul Martin, et al.
Publicado: (2013)

Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer
por: Harada, Kosaku, et al.
Publicado: (2012)

Dosimetric parameters of three new solid core I‐125 brachytherapy sources
por: Solberg, Timothy D., et al.
Publicado: (2002)

I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma
por: Gao, Fu-Lei, et al.
Publicado: (2022)

Clinical efficacy and prognostic factors of CT-guided (125)I brachytherapy for the palliative treatment of retroperitoneal metastatic lymph nodes
por: Yan, Huzheng, et al.
Publicado: (2020)

Clinical efficacy of CT-guided (125)I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation
por: Zhu, Wenliang, et al.
Publicado: (2022)

The dosimetry evaluation of 3D printing non-coplanar template-assisted CT-guided (125)I seed stereotactic ablation brachytherapy for pelvic recurrent rectal cancer after external beam radiotherapy
por: Wang, Hao, et al.
Publicado: (2021)

Assessing dose contribution to pelvic lymph nodes in intracavitary brachytherapy for cervical cancer
por: Chua, Gail Wan Ying, et al.
Publicado: (2017)

Automated estimation of number of implanted iodine-125 seeds for prostate brachytherapy based on two-view analysis of pelvic radiographs
por: Kawata, Hidemichi, et al.
Publicado: (2012)

CT‐guided iodine‐125 brachytherapy as salvage therapy for recurrent mediastinal lymph node metastasis
por: Dong, Hong, et al.
Publicado: (2021)

Three-dimensional template combined with MR-guided iodine-125 brachytherapy for recurrent brain metastases
por: He, Xiangmeng, et al.
Publicado: (2023)

CT-guided iodine-125 brachytherapy as salvage therapy for local-regional recurrent breast cancer
por: Wang, Juan, et al.
Publicado: (2023)

Efficacy and dosimetry analysis of image-guided radioactive (125)I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy
por: Qu, Ang, et al.
Publicado: (2018)

Institutional experience using interstitial brachytherapy for the treatment of primary and recurrent pelvic malignancies
por: Aridgides, Paul, et al.
Publicado: (2016)

Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
por: Njomnang Soh, Patrice, et al.
Publicado: (2013)

An in vitro verification of strength estimation for moving an (125)I source during implantation in brachytherapy
por: Tanaka, Kenichi, et al.
Publicado: (2018)

Clinicopathologic Analysis of Oral Squamous Cell Carcinoma After (125)I Interstitial Brachytherapy
por: Jie, Wei-ping, et al.
Publicado: (2018)

Radiofrequency ablation versus (125)I-seed brachytherapy for painful metastases involving the bone
por: Jiao, Dechao, et al.
Publicado: (2016)

(125)I brachytherapy: a useful treatment to control painful osteoblastic bone metastases
por: Liu, Yiming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ga3i9g9ojnjcog7mopbd0i6b3l